Edgestream Partners »

Amneal Pharmaceuticals shares owned by Edgestream Partners

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Edgestream Partners from 13F filings

Historical chart of Edgestream Partners investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Edgestream Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Edgestream Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $822k 65k 12.60

More positions owned by Edgestream Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Goldman Sachs (GS)
Stryker Corporation (SYK)
Abbvie (ABBV)
Jones Lang LaSalle Incorporated (JLL)
Reliance Steel & Aluminum (RS)

View all positions for Edgestream Partners

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Assenagon Asset Management
Neuberger Berman Group
Millennium Management
Nuveen
Goldman Sachs Group
Nantahala Capital Management
BlackBarn Capital Partners

View all funds holding Amneal Pharmaceuticals